Publications by authors named "Jennifer L Shoemaker"

Claim this Profile
T
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset.
Jennifer L Shoemaker, Kathryn A Seely, Ronald L Reed, John P Crow, Paul L Prather

J Neurochem· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAD(P)H oxidase contributes to the progression of remote hepatic parenchymal injury and endothelial dysfunction, but not microvascular perfusion deficits.
Robert B Dorman, Christian Wunder, Hamida Saba, Jennifer L Shoemaker, Lee Ann MacMillan-Crow

Am J Physiol Gastrointest Liver Physiol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors.
Jennifer L Shoemaker, Michael B Ruckle, Philip R Mayeux, Paul L Prather

J Pharmacol Exp Ther· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptors.
Jennifer L Shoemaker, Biny K Joseph, Michael B Ruckle, Philip R Mayeux, Paul L Prather

J Pharmacol Exp Ther· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis